EVMN – evommune, inc. (US:NASDAQ)
Stock Stats
News
Evommune, Inc. GAAP EPS of -$11.22, revenue of $13M [Seeking Alpha]
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Evommune (NYSE:EVMN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Evommune Announces $125 Million Private Placement
Form S-8 Evommune, Inc.
Form 10-K Evommune, Inc. For: Dec 31
Form 8-K Evommune, Inc. For: Mar 05
Form 4 Evommune, Inc. For: Feb 17 Filed by: LSP 7 Cooperative UA
Form SCHEDULE 13D/A Evommune, Inc. Filed by: LSP 7 Cooperative UA
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.